Search results
Showing 5956 to 5970 of 8314 results
What is the clinical and cost effectiveness of antidepressants for the management of sciatica?
Recommendation ID NG59/6 Question What is the clinical and cost effectiveness of antidepressants for the management of sciatica?
Recommendation ID NG59/1 Question Pharmacological therapies:- What is the clinical and cost effectiveness of benzodiazepines for the acute
Recommendation ID NG59/2 Question Pharmacological therapies:- What is the clinical and cost effectiveness of codeine with and without paracetamol
What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
Recommendation ID NG59/7 Question What is the clinical and cost effectiveness of opioids for the management of acute sciatica? Any
Recommendation ID NG49/5 Question Pharmacological therapy for advanced liver fibrosis in children and young people:- What is the clinical
Recommendation ID CG150/5 Question Pharmacological treatments for headache prophylaxis to aid withdrawal treatment in medication overuse
Recommendation ID NG198/5 Question What is the effectiveness of physical treatments (such as light devices) in the treatment of acne vulgaris
Recommendation ID NG198/7 Question What is the effectiveness of chemical peels for the treatment of acne vulgaris or persistent acne vulgaris-related
Recommendation ID NG71/5 Question Physiotherapy:- Does physiotherapy started early in the course of Parkinson's disease, as opposed to
Recommendation ID NG37/2 Question Pilon fractures:- In adults with closed pilon fractures, what method of fixation provides the best clinical
Recommendation ID CG150/2 Question Pizotifen to prevent recurrent migraine:- Is pizotifen a clinically and cost effective prophylactic
Recommendation ID NG39/1 Question Point-of-care coagulation testing:- What is the clinical and cost effectiveness of point-of-care coagulation
Recommendation ID DG37/3 Question The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled
Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for
Recommendation ID DG37/1 Question The committee recommended further research on the incidence and effect of post-contrast acute kidney